Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Automating neoantigen selection for personalized cancer vaccine design.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells.
Journal: bioRxiv : the preprint server for biology
Published: July 10, 2026
pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.
Journal: ArXiv
Published: July 03, 2026
Concurrent glucocorticoid taper enables reintroduction of alectinib after drug-induced rash.
Journal: JAAD case reports
Published: April 20, 2026
Evaluating the safety and efficacy of chemotherapy in patients with relapsed small cell lung cancer combined with allopurinol and MycoPhenolate (CLAMP).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 12, 2026
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.
Journal: ArXiv
Published: December 19, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 11, 2025
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: January 17, 2024
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry.
Journal: Cancer immunology research
Published: October 26, 2023
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Journal: The Lancet. Oncology
Published: June 07, 2023
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.
Journal: Nature
Published: October 28, 2022
Last Updated: 09/26/2026